Roku Inc. (ROKU) has been having some good days in early November, and it’s perfectly positioned to capitalize on the rise of streaming; but its future is not necessarily certain. The streaming platform has had to deal with some price instability after its quick rise, and now the question of whether its freemium pricing model can meet consumer demand is surfacing. Meanwhile, the digital streaming market is full of tough competitors – and there are two more prominent than ever, ready to hash it out. This is one battle you need to watch closely, as the winner could spell out huge profits for whomever latches on now. Click here to watch.
Archive for 2019
BARCELONA, Spain – Most folks visiting this historic port city on the Balearic sea would focus on seeing tourist-facing sites like the huge and elaborate Sagrada Familia church or the Gothic district.
But I made finding a cannabis club a very high priority.
And this was for two reasons:
- Even though I use edibles to help me sleep at night, my wife and I dared not go through customs with contraband of any kind.
- Having talked to many of you members about global cannabis sales in the years ahead, I wanted to see firsthand how the sector is doing in Europe.
I’m happy to report that cannabis use and sales are on the upswing in this port city and that Europe is set to help drive a global market forecast to hit $15 billion this year.
I recently got the kind of news that no child wants to hear about an aging parent.
Here’s the thing, I count my blessings that my dad lived so long. After all, he’s a retired Marine Corps captain who saw three tours of combat, one in Korea and two in Vietnam.
Honestly he’s lucky he lived as long as he did. But that still doesn’t make the aging process any easier, at least not on the body.
He recently had a second knee replacement that didn’t go as well as planned. He also has swelling of the feet. His mobility is not all that great, and he can’t drive right now.
At 86, he recently learned he has congestive heart failure. That’s a condition in which the heart doesn’t pump as strongly as it should, leading to a buildup of fluids.
As such, my dad is part of a huge trend in America. Fact is, according to the American Heart Association, cardiovascular disease is set to have an economic impact of $1.1 trillion by 2035.
You could forgive drug and biotech executives for having a bad case of target fixation.
After all, they do work in a field that is filled with time-consuming and expensive headaches.
Consider that the Biotechnology Innovation Organization (BIO), the world’s largest biotech trade organization, looked at 7,400 drug programs by 1,103 companies. They were investigating drug-approval rates.
The news was not good -just 9.6% of drugs scientists discover ever get approved for sale. That’s a one-in-ten shot.
With such daunting data, it’s no wonder that, even in a field already worth $1.2 trillion in global sales, industry leaders are on the lookout for ways to lower the cost of discovery and shorten time to market.
And with that goal in mind, I’ve uncovered a high-octane, large-cap firm that has become an essential ingredient in the drug sector’s success.
It’s a cloud-based leader in pharmaceutical efficiency that has a history of crushing the market by no small measure. It’s been doubling its earnings, on average, every 18 months…
My “dad vibe” must be working overtime these days.
And that’s got me thinking maybe my “chance” conversations with a number of young adults lately is a sign of the times.
Let me explain.
As I’ve been going about my routines in the past, I’ve run into a lot of young people who want to get started in investing, but have no clue how to do so.
I’m talking about folks my daughters’ age who are earning some income and want to invest, but just don’t know where to start.
For instance, once, while skiing at the Kirkwood Mountain Resort near Lake Tahoe, I chatted with three young adults who jumped at the chance to get my advice about investing.
I guess that’s where the dad vibe comes into play…. I told them about a surefire way to make the market work for them as though I were talking to my own daughters.
And it just so happens that this investment advice is good for newcomers and old, particularly investors who’ve been reluctant to jump in when market conditions are so volatile.
That’s why today, I’m going to show you not just the one “starter” investment vehicle I suggest for young adults that can set you on the right track…
But I’m going to recommend three other tech-centric ways to jump start your portfolio right now…
There’s a new cutting-edge tech breakthrough that could save the lives of six million Americans in a decade.
Yes, it is potentially a very powerful weapon in the fight against heart disease, which the U.S. Centers for Disease Control and Prevention says causes one in four deaths each year.
Ironically, the technology is in a sector deeply out of favor with Wall Street.
But that’s just fine with us. At Strategic Tech Investor, we know the huge profit potential in bucking the Street’s herd mentality.
And you couldn’t pick a more exciting field than 3D-printed human organs.
Here’s the thing. Scientists in Israel printed a tiny heart in April, complete with blood vessels, using a patient’s cells.
Even better, they pulled off this amazing achievement in just three hours.
That’s why today, I’m going to show you what I believe is the best market-crushing play on the future of 3D printing tech used to save lives…
My daughters, ages 20 and 23, are a little bit bummed right now.
See, one of their favorite retail stores has just filed for bankruptcy protection. As a result, Forever 21 intends to close 178 stores in the U.S. and another 172 around the world.
Kendall and Jordan have been going to one of the local stores for many years. They like the wide selection of trendy clothes, shoes, and accessories at discount prices.
Here’s the thing: their other favorite place to shop continues to put lagging retailers under pressure to perform in the fast moving online world.
Growing up in a tech-centric home, both my daughters take shopping at Amazon.com Inc. (AMZN) as a given. Much to their dad’s chagrin, they do it all the time – and I do mean all the time.
But what most people miss here is that Amazon now relies on thousands of other companies to sell through the firm’s unbeatable storefront.
According to Statista, Amazon’s websites receive 209.7 million unique visitors every month from the U.S. alone, with most of the purchases they make coming from third-party sellers.
As fears of overexposure to the China trade dispute in the microchip and semiconductor sectors are being proven wrong, the market rallies. Investors are realizing that the banned Chinese company, Huawei, is not as tightly woven into those sectors as it had feared, and strong demand for chips will be driven on by the pending rollout of 5G technology. This means that those entire sectors are currently undervalued. As the new 5G upgrade cycle promises to keep demand high for years to come, there’s one company in this sector whose sales are up 24% since the market rally, and whose earnings are doubling nearly every three years – meaning huge growth potential if you latch on now. Click here to watch.
If all you did was look at the headlines, you’d think this is a terrible time to invest in initial public offerings (IPOs).
Just take a look at this recent riff from Forbes, “Why WeWork Won’t Work! – Hello Neumann!,” or Bloomberg’s announcement, “Endeavor Makes Last-Minute Call to Yank IPO as Conditions Sour.” Big time financial news is clearly in love with the idea that anyone getting hyped up for a big name IPO is just setting themselves up for disappointment.
On paper, that narrative makes sense.
WeWork’s attempt at an IPO saw an optimistic estimated valuation of $47 billion falling to less than $14 billion before the offering was abandoned entirely. The loss was so devastating that the CEO resigned over it.
Not only that, but Peloton Interactive Inc. (PTON) dropped 11.2% in its first day of trading on Sept. 26, a decline which, according to The Wall Street Journal, directly influenced the decision of talent firm, The Endeavor Group, to also put off its own new stock debut out of fear of poor market conditions.
But what the media isn’t telling you is that tech and life sciences firms are still IPO leaders. That segment of the market is actually doing quite well overall.
Last week, I was in Las Vegas presenting at the first annual retreat of our sister operation, the National Institute for Cannabis Investors (NICI). While I was there, I realized just how many investors need to know what’s going on with the markets and the economy, and how they can be prepared for whatever chaos gets thrown at them.
The fact is, the S&P 500 was down on Oct. 2, up on Oct. 4, down on Oct. 8, and up again yesterday. The situation is crazier than ever.
That’s why it’s time to buckle up and learn the tools you’ll need to protect your profits in a sideways market.
The key to staying afloat will be your skills at portfolio management. Inparticular, you’ll need two of my favorite techniques that are perfect for times like these.